2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Dosimetric analysis of Co-60 source based high dose rate (HDR) brachytherapy: A case series of ten patients with carcinoma of the uterine cervix

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="d6259910e194"> <!-- named anchor --> </a> <h5 class="section-title" id="d6259910e195">Aim</h5> <p id="d6259910e197">To analyse the dosimetric parameters of Co-60 based high dose rate (HDR) brachytherapy plans for patients of carcinoma uterine cervix. </p> </div><div class="section"> <a class="named-anchor" id="d6259910e199"> <!-- named anchor --> </a> <h5 class="section-title" id="d6259910e200">Background</h5> <p id="d6259910e202">Co-60 high dose rate (HDR) brachytherapy unit has been introduced in past few years and is gaining importance owing to its long half life, economical benefits and comparable clinical outcome compared to Ir-192 HDR brachytherapy. </p> </div><div class="section"> <a class="named-anchor" id="d6259910e204"> <!-- named anchor --> </a> <h5 class="section-title" id="d6259910e205">Materials and methods</h5> <p id="d6259910e207">A study was conducted on ten patients with locally advanced carcinoma of the uterine cervix (Ca Cx). Computed tomography (CT) images were taken after three channel applicator insertions. The planning for 7 Gray per fraction (7 Gy/#) was done for Co-60 HDR brachytherapy unit following the American Brachytherapy Society (ABS) guidelines. All the patients were treated with 3# with one week interval between fractions. </p> </div><div class="section"> <a class="named-anchor" id="d6259910e209"> <!-- named anchor --> </a> <h5 class="section-title" id="d6259910e210">Results</h5> <p id="d6259910e212">The mean dose to high risk clinical target volumes (HRCTV) for D <sub>90</sub> (dose to 90% volume) was found to be 102.05% (Standard Deviation (SD): 3.07). The mean D <sub>2cc</sub> (dose to 2 cubic centimeter volume) of the bladder, rectum and sigmoid were found to be 15.9 Gy (SD: 0.58), 11.5 Gy (SD: 0.91) and 4.1 Gy (SD: 1.52), respectively. </p> </div><div class="section"> <a class="named-anchor" id="d6259910e220"> <!-- named anchor --> </a> <h5 class="section-title" id="d6259910e221">Conclusion</h5> <p id="d6259910e223">The target coverage and doses to organs at risk (OARs) were achieved as per the ABS guidelines. Hence, it can be concluded that the Co-60 HDR brachytherapy unit is a good choice especially for the centers with a small number of brachytherapy procedures as no frequent source replacement is required like in an Ir-192 HDR unit. </p> </div>

          Related collections

          Author and article information

          Journal
          Reports of Practical Oncology & Radiotherapy
          Reports of Practical Oncology & Radiotherapy
          Elsevier BV
          15071367
          May 2016
          May 2016
          : 21
          : 3
          : 201-206
          Article
          10.1016/j.rpor.2016.01.003
          5002016
          27601951
          0de8722d-9a8c-4ac8-8b93-1daa56d810a4
          © 2016

          https://www.elsevier.com/tdm/userlicense/1.0/

          https://www.elsevier.com/open-access/userlicense/1.0/

          History

          Comments

          Comment on this article